Armistice Capital »

Boston Scientific Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 23k 77.01
2020-12-31 $18M 500k 35.95

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Boston Scientific Corporation

Vanguard Group
BlackRock
BlackRock
State Street Corporation
PRIMECAP Management Company
Bank of America Corporation
Geode Capital Management
Jpmorgan Chase & Co
Massachusetts Financial Services
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors
Bollard
Morgan Stanley
Henderson Group
Franklin Resources

View all funds holding Boston Scientific Corporation